A Further Case of a t(11;20)(p15;q11.2) Translocation in an Acute Myeloid Leukemia (FAB M2)
- 1 January 1998
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 20 (1) , 91-93
- https://doi.org/10.1097/00043426-199801000-00017
Abstract
The clinical implications of many cytogenetic abnormalities in acute myeloid leukemia (AML) are now well established. However, questions about the significance of rarer abnormalities still exist, particularly in childhood disease. We report a case of a 9 1/2-year-old girl who had AML of the FAB M2 subtype. A diagnostic bone marrow aspirate and subsequent bone marrow aspirates were investigated using conventional cytogenetic methods. Cytogenetic analysis of the diagnostic bone marrow aspirate showed a t(1;20)(p15;q11.2) translocation as the sole acquired abnormality. After one course of chemotherapy, the patient achieved hematopoietic and cytogenetic remission which has been sustained for 1 year after presentation. This report demonstrates that rare non-random cytogenetic abnormalities are still to be described in AML, and that care should be taken when ascribing clinical significance to cytogenetic findings in childhood disease based on those of older patients.Keywords
This publication has 5 references indexed in Scilit:
- The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9Nature Genetics, 1996
- Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemiaNature Genetics, 1996
- Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87Blood, 1995
- Cytogenetics in acute myeloid leukaemiaBlood Reviews, 1994
- Clinical significance of the del(20q) chromosome in hematologic disordersCancer Genetics and Cytogenetics, 1992